Selected research
Industry Research
Skin Active Delivery System Industry Research Report 2026
Market perspective
The global Skin Active Delivery System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Skin Active Delivery System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Skin Active Delivery System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Skin Active Delivery System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Skin Active Delivery System include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Corium, Nitto, Valeritas, Nanopass Technologies, TheraJect, Inc and Vaxxas, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Skin Active Delivery System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Skin Active Delivery System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Skin Active Delivery System Market by Company
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Corium
Nitto
Valeritas
Nanopass Technologies
TheraJect, Inc
Vaxxas
Microdermics
Lohmann Therapie-Systeme AG
BASF
3M
Evonik Personal Care
Vantage Personal Care
Minerals Technologies
Bicosome
Skin Active Delivery System Segment by Type
Microcapsules
Base Oil
Microneedle Technology
Skin Active Delivery System Segment by Application
Drug
Cosmetic
Skin Active Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Active Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Active Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Active Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Skin Active Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microcapsules
- Base Oil
- Microneedle Technology
Applications
- Drug
- Cosmetic
Companies covered
- KINDEVA
- Zosano Pharma
- Becton-Dickinson(BD)Technologies
- Corium
- Nitto
- Valeritas
- Nanopass Technologies
- TheraJect, Inc
- Vaxxas
- Microdermics
- Lohmann Therapie-Systeme AG
- BASF
- 3M
- Evonik Personal Care
- Vantage Personal Care
- Minerals Technologies
- Bicosome
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Skin Active Delivery System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Microcapsules
- 2.2.3 Base Oil
- 2.2.4 Microneedle Technology
- 2.3 Skin Active Delivery System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug
- 2.3.3 Cosmetic
- 2.4 Assumptions and Limitations
3 Skin Active Delivery System Breakdown Data by Type
- 3.1 Global Skin Active Delivery System Historic Market Size by Type (2021-2026)
- 3.2 Global Skin Active Delivery System Forecasted Market Size by Type (2027-2032)
4 Skin Active Delivery System Breakdown Data by Application
- 4.1 Global Skin Active Delivery System Historic Market Size by Application (2021-2026)
- 4.2 Global Skin Active Delivery System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Skin Active Delivery System Market Perspective (2021-2032)
- 5.2 Global Skin Active Delivery System Growth Trends by Region
- 5.2.1 Global Skin Active Delivery System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Skin Active Delivery System Historic Market Size by Region (2021-2026)
- 5.2.3 Skin Active Delivery System Forecasted Market Size by Region (2027-2032)
- 5.3 Skin Active Delivery System Market Dynamics
- 5.3.1 Skin Active Delivery System Industry Trends
- 5.3.2 Skin Active Delivery System Market Drivers
- 5.3.3 Skin Active Delivery System Market Challenges
- 5.3.4 Skin Active Delivery System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Skin Active Delivery System Players by Revenue
- 6.1.1 Global Top Skin Active Delivery System Players by Revenue (2021-2026)
- 6.1.2 Global Skin Active Delivery System Revenue Market Share by Players (2021-2026)
- 6.2 Global Skin Active Delivery System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Skin Active Delivery System Head Office and Area Served
- 6.4 Global Skin Active Delivery System Players, Product Type & Application
- 6.5 Global Skin Active Delivery System Manufacturers Established Date
- 6.6 Global Skin Active Delivery System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Skin Active Delivery System Market Size (2021-2032)
- 7.2 North America Skin Active Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Skin Active Delivery System Market Size by Country (2021-2026)
- 7.4 North America Skin Active Delivery System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Skin Active Delivery System Market Size (2021-2032)
- 8.2 Europe Skin Active Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Skin Active Delivery System Market Size by Country (2021-2026)
- 8.4 Europe Skin Active Delivery System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Skin Active Delivery System Market Size (2021-2032)
- 9.2 Asia-Pacific Skin Active Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Skin Active Delivery System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Skin Active Delivery System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Skin Active Delivery System Market Size (2021-2032)
- 10.2 South America Skin Active Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Skin Active Delivery System Market Size by Country (2021-2026)
- 10.4 South America Skin Active Delivery System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Skin Active Delivery System Market Size (2021-2032)
- 11.2 Middle East & Africa Skin Active Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Skin Active Delivery System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Skin Active Delivery System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 KINDEVA
- 12.1.1 KINDEVA Company Information
- 12.1.2 KINDEVA Business Overview
- 12.1.3 KINDEVA Revenue in Skin Active Delivery System Business (2021-2026)
- 12.1.4 KINDEVA Skin Active Delivery System Product Portfolio
- 12.1.5 KINDEVA Recent Developments
- 12.2 Zosano Pharma
- 12.2.1 Zosano Pharma Company Information
- 12.2.2 Zosano Pharma Business Overview
- 12.2.3 Zosano Pharma Revenue in Skin Active Delivery System Business (2021-2026)
- 12.2.4 Zosano Pharma Skin Active Delivery System Product Portfolio
- 12.2.5 Zosano Pharma Recent Developments
- 12.3 Becton-Dickinson(BD)Technologies
- 12.3.1 Becton-Dickinson(BD)Technologies Company Information
- 12.3.2 Becton-Dickinson(BD)Technologies Business Overview
- 12.3.3 Becton-Dickinson(BD)Technologies Revenue in Skin Active Delivery System Business (2021-2026)
- 12.3.4 Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio
- 12.3.5 Becton-Dickinson(BD)Technologies Recent Developments
- 12.4 Corium
- 12.4.1 Corium Company Information
- 12.4.2 Corium Business Overview
- 12.4.3 Corium Revenue in Skin Active Delivery System Business (2021-2026)
- 12.4.4 Corium Skin Active Delivery System Product Portfolio
- 12.4.5 Corium Recent Developments
- 12.5 Nitto
- 12.5.1 Nitto Company Information
- 12.5.2 Nitto Business Overview
- 12.5.3 Nitto Revenue in Skin Active Delivery System Business (2021-2026)
- 12.5.4 Nitto Skin Active Delivery System Product Portfolio
- 12.5.5 Nitto Recent Developments
- 12.6 Valeritas
- 12.6.1 Valeritas Company Information
- 12.6.2 Valeritas Business Overview
- 12.6.3 Valeritas Revenue in Skin Active Delivery System Business (2021-2026)
- 12.6.4 Valeritas Skin Active Delivery System Product Portfolio
- 12.6.5 Valeritas Recent Developments
- 12.7 Nanopass Technologies
- 12.7.1 Nanopass Technologies Company Information
- 12.7.2 Nanopass Technologies Business Overview
- 12.7.3 Nanopass Technologies Revenue in Skin Active Delivery System Business (2021-2026)
- 12.7.4 Nanopass Technologies Skin Active Delivery System Product Portfolio
- 12.7.5 Nanopass Technologies Recent Developments
- 12.8 TheraJect, Inc
- 12.8.1 TheraJect, Inc Company Information
- 12.8.2 TheraJect, Inc Business Overview
- 12.8.3 TheraJect, Inc Revenue in Skin Active Delivery System Business (2021-2026)
- 12.8.4 TheraJect, Inc Skin Active Delivery System Product Portfolio
- 12.8.5 TheraJect, Inc Recent Developments
- 12.9 Vaxxas
- 12.9.1 Vaxxas Company Information
- 12.9.2 Vaxxas Business Overview
- 12.9.3 Vaxxas Revenue in Skin Active Delivery System Business (2021-2026)
- 12.9.4 Vaxxas Skin Active Delivery System Product Portfolio
- 12.9.5 Vaxxas Recent Developments
- 12.10 Microdermics
- 12.10.1 Microdermics Company Information
- 12.10.2 Microdermics Business Overview
- 12.10.3 Microdermics Revenue in Skin Active Delivery System Business (2021-2026)
- 12.10.4 Microdermics Skin Active Delivery System Product Portfolio
- 12.10.5 Microdermics Recent Developments
- 12.11 Lohmann Therapie-Systeme AG
- 12.11.1 Lohmann Therapie-Systeme AG Company Information
- 12.11.2 Lohmann Therapie-Systeme AG Business Overview
- 12.11.3 Lohmann Therapie-Systeme AG Revenue in Skin Active Delivery System Business (2021-2026)
- 12.11.4 Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio
- 12.11.5 Lohmann Therapie-Systeme AG Recent Developments
- 12.12 BASF
- 12.12.1 BASF Company Information
- 12.12.2 BASF Business Overview
- 12.12.3 BASF Revenue in Skin Active Delivery System Business (2021-2026)
- 12.12.4 BASF Skin Active Delivery System Product Portfolio
- 12.12.5 BASF Recent Developments
- 12.13 3M
- 12.13.1 3M Company Information
- 12.13.2 3M Business Overview
- 12.13.3 3M Revenue in Skin Active Delivery System Business (2021-2026)
- 12.13.4 3M Skin Active Delivery System Product Portfolio
- 12.13.5 3M Recent Developments
- 12.14 Evonik Personal Care
- 12.14.1 Evonik Personal Care Company Information
- 12.14.2 Evonik Personal Care Business Overview
- 12.14.3 Evonik Personal Care Revenue in Skin Active Delivery System Business (2021-2026)
- 12.14.4 Evonik Personal Care Skin Active Delivery System Product Portfolio
- 12.14.5 Evonik Personal Care Recent Developments
- 12.15 Vantage Personal Care
- 12.15.1 Vantage Personal Care Company Information
- 12.15.2 Vantage Personal Care Business Overview
- 12.15.3 Vantage Personal Care Revenue in Skin Active Delivery System Business (2021-2026)
- 12.15.4 Vantage Personal Care Skin Active Delivery System Product Portfolio
- 12.15.5 Vantage Personal Care Recent Developments
- 12.16 Minerals Technologies
- 12.16.1 Minerals Technologies Company Information
- 12.16.2 Minerals Technologies Business Overview
- 12.16.3 Minerals Technologies Revenue in Skin Active Delivery System Business (2021-2026)
- 12.16.4 Minerals Technologies Skin Active Delivery System Product Portfolio
- 12.16.5 Minerals Technologies Recent Developments
- 12.17 Bicosome
- 12.17.1 Bicosome Company Information
- 12.17.2 Bicosome Business Overview
- 12.17.3 Bicosome Revenue in Skin Active Delivery System Business (2021-2026)
- 12.17.4 Bicosome Skin Active Delivery System Product Portfolio
- 12.17.5 Bicosome Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst